financetom
Business
financetom
/
Business
/
Target Poised for Fiscal Q2 Recovery With Focus on Value Strategy, Gross Margin Gains, BofA Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Target Poised for Fiscal Q2 Recovery With Focus on Value Strategy, Gross Margin Gains, BofA Says
Aug 19, 2024 8:24 AM

11:12 AM EDT, 08/19/2024 (MT Newswires) -- Target ( TGT ) will likely see a return to year-over-year comparable sales growth in fiscal Q2 due to easier comparisons and the company's focus on value offerings, BofA Securities said in an earnings preview on Monday.

Target ( TGT ) is scheduled to report its fiscal Q2 results on Wednesday.

The firm said it expects gross margins to get support from cost savings initiatives, lean inventory levels, favorable product mix and potentially moderating shrinkage issues.

BofA expects Target's ( TGT ) near-term and long-term trends to improve and this outweighs risks related to discretionary spending, competition and slower pace of gross margin recovery.

"Target's ( TGT ) heightened focus on value positions it well for share gains going forward including improving price gaps and several new owned brand launches focused on value and entry-level price points," the firm said.

BofA reiterated its buy rating on Target's ( TGT ) stock, with a price objective of $190.

Shares of the company were up more than 1% in recent trading.

Price: 145.82, Change: +1.78, Percent Change: +1.24

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ConocoPhillips Acquires Marathon Oil In All-Stock Deal At 14.7% Premium: Details
ConocoPhillips Acquires Marathon Oil In All-Stock Deal At 14.7% Premium: Details
May 29, 2024
Marathon Oil Corporation ( MRO ) and ConocoPhillips ( COP ) stocks are moving in opposite directions on Wednesday after they disclosed a definitive deal in which ConocoPhillips ( COP ) will acquire Marathon Oil ( MRO ) in an all-stock transaction with an enterprise value of $22.5 billion. As per the agreement, Marathon Oil ( MRO ) shareholders will...
Immunocore Converts Skin Cancer Therapy Phase 2/3 Trial to Phase 3
Immunocore Converts Skin Cancer Therapy Phase 2/3 Trial to Phase 3
May 29, 2024
08:14 AM EDT, 05/29/2024 (MT Newswires) -- Immunocore Holdings ( IMCR ) said Wednesday a phase 2/3 trial evaluating its therapy candidate, Kimmtrak as a monotherapy and in combination with pembrolizumab to treat certain patients with skin cancer has been converted into a phase 3 trial. The decision comes following a consultation with the US Food and Drug Administration, the...
Milestone Pharmaceuticals Says US FDA Accepts New Drug Application for Cardamyst Nasal Spray for Arrhythmia
Milestone Pharmaceuticals Says US FDA Accepts New Drug Application for Cardamyst Nasal Spray for Arrhythmia
May 29, 2024
08:10 AM EDT, 05/29/2024 (MT Newswires) -- Milestone Pharmaceuticals ( MIST ) said Wednesday that the US Food and Drug Administration has accepted its New Drug Application for Cardamyst nasal spray for the management of paroxysmal supraventricular tachycardia, or PSVT, a type of arrhythmia or abnormal heart rhythm. The company said the regulator's Prescription Drug User Fee Act target date...
Redwire Forms Coalition to Support Research Projects, AI in Space Operations
Redwire Forms Coalition to Support Research Projects, AI in Space Operations
May 29, 2024
08:14 AM EDT, 05/29/2024 (MT Newswires) -- Redwire ( RDW ) said Wednesday it has formed a coalition that will fund research projects focusing on using artificial intelligence in space operations. Redwire ( RDW ) is one of the two corporate sponsors of the Center for AEroSpace Autonomy Research, or CAESAR, at Stanford University, which aims to leverage various disciplines...
Copyright 2023-2026 - www.financetom.com All Rights Reserved